TACSTD2 and breast cancer: Previously, it was reported that TROP2 is predominantly overexpressed in various tumor types, including UC, BC, cervical cancer, CRC, lung cancer, ovarian cancer, pancreatic cancer, thyroid cancer, endometrial cancer [12].